News & Events

1802_FTS-AGV-591
01.02.2018

DYCONEX opts for automated guided vehicles

DYCONEX AG successfully tests the production use of self-driving transport robots with a view to automating internal goods flows between departments and clean room zones.

MST at IMAPS Device Packaging 2018 - USA

IMAPS
Device Packaging
March 6 - 7, 2018
We-ko-Pa Resort and Casino
Scottsdale/Fountain Hills, AZ, USA
Booth# 28

DYCONEX at Bodensee Aerospace Meeting 2018

bam-logo

Conference for the German-speaking aviation and space industry 
March 22, 2018
Priora Business Center, Zurich, Switzerland

Please note, the event will mainly be held in German. 


DYCONEX LIQUID CRYSTAL POLYMER (LCP) SUBSTRATE PROVES CYTOTOXICITY CONFORMITY ACCORDING TO ISO 10993-5

Cytotoxicity, a standardized test for materials used in medical devices, is used to determine if significant quantities of harmful extractable substances are present and how these may negatively affect cellular components. Harlan Cytotest Cell Research GmbH recently performed a cytotoxicity test on an LCP product manufactured by DYCONEX and certified in an official declaration the non-cytotoxicity of the product and it's suitability for in-vitro application.

Due to its biocompatibility, hermeticity properties, chemical inertness and advantageous electromechanical properties, LCP circuit boards are especially well-suited for biomedical and temporary implantable applications.